New York A01428 requires insurers to cover brand name prescription drugs when there is a supply issue with the generic version.
New York A01428 amends the insurance law to mandate that insurers cover brand name prescription drugs when the federal Food and Drug Administration declares a supply issue with the generic version. This applies to insureds who are already receiving the generic drug or have a condition treated by it. The brand name drug must be covered at the same level as the generic until the supply issue is resolved. This provision aims to ensure continuity of care during drug shortages.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.